30 Aug
|
Parabilis Medicines
|
Hobart
30 Aug
Parabilis Medicines
Hobart
Parabilis Medicines is seeking an In Vivo Study Specialist to drive preclinical evaluation of Helicon peptide therapeutics in oncology.
You will perform in vivo studies across xenograft, syngeneic, PDX, and GEMM models, and prepare ex vivo tissue for downstream analyses, collaborating with Discovery Biology, Translational Sciences, and DMPK.
The role requires hands-on in vivo expertise, tissue processing skills, and solid communication.
#J-*****-Ljbffr
📌 In Vivo Oncology Study Specialist — Drive Preclinical Impact (Hobart)
🏢 Parabilis Medicines
📍 Hobart